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Our previous studies had shown that platelet activating factor
(PAF) was an important mediator of vascular leak. We found that
although the dengue virus (DENV) or dengue immune serum did
not induce PAF production by monocytes, lipopolysaccharide (LPS)
acted synergistically with the DEN, in the production of PAF. Since
LPS levels in serum have been found to be signiﬁcantly elevated
in SD, LPS could further contribute to disease pathogenesis and
vascular leak.
Mast cells are an important source of PAF and have shown to
be important in disease pathogenesis in dengue mice models. We
found thatmediators such as tryptase and secretoryphospholipase,
which are produced exclusively by mast cells, are signiﬁcantly ele-
vated in patients with DHF, during early infection. Therefore, in
summary, the events that lead to severe dengue appear to occur
before the onset of vascular leak and the role of mast cells and viral
proteins in the pathogenesis of SD should be further investigated.
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Abstract: Dengue is an important human arboviral disease
caused by infection of four antigenically related strains of dengue
virus (DENV 1-4) belonging to the Flaviviridae family. Despite
extensive worldwide efforts, it remains a major public health con-
cern with 55% of the world’s population estimated to be at risk
for dengue. Infection by any of the four dengue serotypes can
cause a wide spectrum of disease manifestations that ranges from
mild, self-limiting febrile dengue fever to severe, life-threatening
disease. The pathophysiological hallmark that determines disease
severity is the degree of plasma leakage, bleeding and single or
mutli-organ involvement. In recent years, there were several clini-
cal trials using re-purposed pharmaceutical agents to treat dengue,
however none has shown signiﬁcant usefulness for its recommen-
dation for routine use. Lacking the anti-viral agents, management
of dengue is largely supportive in nature. Ability to recognise infec-
tion early and early signs of disease progression remain key in
instituting early and appropriate interventions, preventing dis-
ease progression or late presentation of disease where treatment
options are limited and outcomes are poor. Patients with severe
dengue should be admitted to a hospital with access to intensive
care facilities. Judicious intravenous ﬂuid replacement is critical
to balance the 2 stages between plasma leakage and ﬂuid re-
absorption during recovery phase. Dengue is a dynamic disease
particularly so during the critical phase where plasma volume
changes rapidly, close and frequent monitoring of hematocrit is
critical to guide ﬂuid replacement. Concealed bleeding may pose a
clinical challenge and in instance blood transfusionmay be needed.
Denguemortality can be reducedwith systempriming to recognise
the disease and systematic treatment approach.
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Abstract: Leptospirosis is present worldwide and is especially
important in developing countries, where sanitation is precari-
ous. Sporadic cases are linked to contact with urine-contaminated
water. In tropical countries, urban outbreaks can occur after ﬂoods
in rainy season. Mild non-lethal anicteric forms comprise most
cases and can be easily confused with ﬂu, dengue fever, other
mild viral illnesses and P. vivax malaria. About 5 to 10% of cases
develop severe sepsis-like disease or meningitis during outbreaks.
The serious illness form, also known as Weil’s Disease, courses
with jaundice, shock, renal failure, coagulopathy and other organ
dysfunctions, leading to prolonged hospitalization in intensive
care facilities and death, with high healthcare costs. Differential
diagnosis includes bacterial sepsis, hepatitis, yellow fever, Han-
tavirus disease, P. falciparum malaria and other severe febrile
illnesses. Highly sensitive and speciﬁc rapid diagnosis tests are
commercially lacking. Antibodies or antigen detection by enzyme-
linked assays and nucleic acid detection by PCR in blood or
other body ﬂuids are promising. Mechanisms of disease are little
known, but evidence points out to systemic inﬂammatory response
syndrome-like pathophysiology in severe cases. Spirochete cell
wall proteins, lipopolysaccharide, enzymes like phospholipase and
other bacterial toxic products produce tissue damage and activate
inﬂammatory response locally and systemically, through toll-like
receptors on antigen-presenting cells, triggering cytokine secretion
by innate andadaptive immunecells, resulting in inﬂammatoryand
immune responses. Some patients evolve with shock, coagulopa-
thy, organ failure and death. Which regulatory mechanism leads
to severe disease is not exactly known. Lethality varies widely in
severe cases, reaching 50% in some reports, depending of diagno-
sis and treatment institution speed, level of care and other factors.
